Africure Pharmaceuticals Ltd Stock

AFRP.N0000

MU0713N00001

End-of-day quote Mauritius S.E. Other stock markets 31/07/2026			5-day change	1st Jan Change
6.060 ^USD	-.--%		-.--%	-

06-23	Africure Pharmaceuticals Ltd Delays Earnings Results Release for the Year Ended March 31, 2026	CI
08/08/25	Africure Pharmaceuticals Ltd Announces Delay in the Interim Results for the Three Months Ended 30 June 2025	CI

Chart: Africure Pharmaceuticals Ltd

Dynamic Chart

Latest news : Africure Pharmaceuticals Ltd

06-23	Africure Pharmaceuticals Ltd Delays Earnings Results Release for the Year Ended March 31, 2026	CI
08/08/25	Africure Pharmaceuticals Ltd Announces Delay in the Interim Results for the Three Months Ended 30 June 2025	CI
11/02/25	Africure Pharmaceuticals Ltd Announces Delay in Publication of Unaudited Financial Statements for the Three Months and Nine Months Ended 31 December 2024	CI

More news

Press Releases: Africure Pharmaceuticals Ltd

10/02/25

Africure Pharmaceuticals : Communique

More press releases

Managers and Directors: Africure Pharmaceuticals Ltd

Manager	Title	Age	Since
Sinhue Bosco Noronha CEO	Chief Executive Officer	66	22/03/2017
Ravi Shankar Chandrasekhar DFI	Director of Finance/CFO	43	22/03/2017

Director	Title	Age	Since
Sinhue Bosco Noronha BRD	Director/Board Member	66	22/03/2017
Ravi Shankar Chandrasekhar BRD	Director/Board Member	43	22/03/2017
Sultunti Asnath BRD	Director/Board Member	51	17/03/2017

More insiders

Africure Pharmaceuticals Limited is specialized in manufacturing and marketing generic medicines. The group offers antibiotics, anti-inflammatories, analgesics, antivirals, antimalarials, etc. At the end of March 2024, the group had 5 production sites located in India, Cameroon, Botswana, Côte d'Ivoire, Tanzania, and Ethiopia.

Employees

Sector

More about the company